ARCHIVES

Revive Comprehensive Program, But Don’t Tie It to Grant Review, Center Executive Agrees

This article is from The Cancer Letter archive.

Vol. 14 No. 31 | July 29, 1988

Download PDF Visit The Full Archive

Related Articles

Four Win 1988 General Motors Cancer Prizes

June 17, 1988

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

FDA Designates Zometa For Priority Review.

November 30, 2001

Black Women More Likely To Have Aggressive, Less Treatable Breast Cancer

September 28, 2007

NIH director; Targets Increases Favor Established Researchers

May 9, 1997

Treatment Doesn’t Always Follow Recommendations

February 25, 2005